Search results
Results From The WOW.Com Content Network
The bottom line. Zinc helps you maintain a healthy immune system. It has been proven to reduce the severity and duration of colds, but cannot cure one. Zinc is also important for metabolic ...
Zinc and the common cold. Zinc supplements (frequently zinc acetate or zinc gluconate lozenges) are a group of dietary supplements that are commonly used in an attempt to treat the common cold. [1] Evidence of any benefit is weak, but it seems zinc may not prevent colds, but possibly reduce their length while not reducing the severity of the ...
Zinc deficiency is defined either as insufficient zinc to meet the needs of the body, or as a serum zinc level below the normal range. However, since a decrease in the serum concentration is only detectable after long-term or severe depletion, serum zinc is not a reliable biomarker for zinc status. [1] Common symptoms include increased rates of ...
For premium support please call: 800-290-4726 more ways to reach us
Zinc is refined by froth flotation of the ore, roasting, and final extraction using electricity (electrowinning). Zinc is an essential trace element for humans, [ 6 ][ 7 ][ 8 ] animals, [ 9 ] plants [ 10 ] and for microorganisms [ 11 ] and is necessary for prenatal and postnatal development. [ 12 ]
Zinc gluconate has been used in lozenges for treating the common cold. However, controlled trials with lozenges which include zinc acetate have found it has the greatest effect on the duration of colds. [3] [4] Zinc has also been administered nasally for treating the common cold, but has been reported to cause anosmia in some cases. [5] [6] [7] [8]
The use of zinc sulfate supplements together with oral rehydration therapy decreases the number of bowel movements and the time until the diarrhea stops. [2] Its use in this situation is recommended by the World Health Organization. [2] There is some evidence zinc is effective in reducing hepatic and neurological symptoms of Wilson's disease. [9]
The Age-Related Eye Disease Study (AREDS) was a clinical trial sponsored by the National Eye Institute that ran from 1992 to 2001. [1] The study was designed to: investigate the natural history and risk factors of age-related macular degeneration (AMD) and cataracts, and. evaluate the effects of high doses of antioxidants and zinc on the ...